An Incisive, In-depth Analysis on the India Coronary Stent Market
This study offers a comprehensive, 360 degree analysis on the India Coronary Stent market, bringing to fore insights that can help stakeholders identify the opportunities as well as challenges. It tracks the global India Coronary Stent market across key regions, and offers in-depth commentary and accurate quantitative insights. The study also includes incisive competitive landscape analysis, and provides key recommendations to market players on winning imperatives and successful strategies.
Coronary stent is an expandable tube device used to keep the artery open during treatment of coronary heart disease. It is placed in arteries that supply blood to the heart during a procedure called percutaneous coronary intervention (PCI) or angioplasty. The procedure helps reduce chest pain (angina) and increase survival rate of patients. Increasing PCI procedure in India is expected to drive demand for coronary stents, as risk of coronary heart disease is higher among elderly individuals, owing to increasing prevalence of diabetes, acute coronary syndromes and hypertension along with relatively fast detection of disease. Furthermore, increasing per capita income, strong healthcare infrastructure and well established reimbursements are soaring demand for coronary stents in India. India coronary stents market is segmented by product type, raw material and end user.
Market Value and Forecast
India coronary stents market is estimated to be valued at US$ 531 Mn by 2016 end and is expected to expand at a CAGR of 14.0% over the forecast period (2016–2026)
Demand for coronary stents is currently witnessing robust growth in India, mainly due to FDA approval for new stents and increasing number of PCI procedures in hospitals. The coronary stents market in India is mainly dominated by MNCs, accounting for the largest share of 70%. Rising health consciousness and increased healthcare expenditure is expected to drive the market in near future. Macroeconomic factors such as favourable government reimbursement policies and increase in FDI in healthcare sector is further projected to drive growth of the market. Other prominent growth drivers include rapidly growing medical technology industry and rising affordability of CHD treatment. However, chances of restenosis after angioplasty is a major factor expected to hamper overall growth of coronary stents market over the forecast period. Moreover, lack of well-established distribution channel associated with stents increases overall cost associated with it, which in turn is negatively impacting overall adoption of stents in the country.
Market Segmentation by Product
On the basis of product type, the market has been segmented into Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bioresorbable stent (BVS). Drug Eluting Stent product type segment is expected to exhibit the highest growth over the forecast period. BMS segment is expected to exhibit stable growth during the forecast period. This is mainly attributed to emergence of new and effective stents in the market, which are expected to stabilize growth of the BMS segment.
Market Segmentation by Raw Material
On the basis of raw material, the market has been segmented into cobalt-chromium, stainless steel, platinum-chromium, nickel-titanium and polymer. Cobalt-chromium segment is expected to exhibit the highest growth over the forecast period, followed by platinum-chromium segment. Development of new stents owing to increasing investment in the healthcare sector along with high efficacy and safety of raw materials that increase lifespan of stents.
Market Segmentation by End User
On the basis of end user, the market has been segmented into hospitals, ambulatory surgical centres, and cardiac catheterization laboratories. Hospitals segment accounts for the highest revenue share in the India coronary stents market, followed by ambulatory surgical centres and cardiac catheterization laboratories segments, respectively. Increasing patient population seeking effective and efficient treatment at low cost is a key factor driving adoption of new medical devices and technologies in hospitals
Some key players in the global infusion pumps market identified in this report are Abbott Laboratories, Medtronic, Inc., Biosensors Inc., and Boston Scientific Inc. The report also identifies company-specific strategies related to product development, market consolidation initiatives and analysis of their specific strengths, weaknesses, opportunities and threats.
Future Market Insights (FMI) offers a 10-year forecast of the India coronary stents market between 2016 and 2026. In terms of value, the market is expected to register a CAGR of 14.0% over the forecast period. This study demonstrates market dynamics and trends that influence the current environment and future status of the coronary stents market in India over the forecast period.
This Future Market Insights report examines India coronary stents market for the period 2016–2026. The primary objective of the report is to offer insights on various coronary stents market products such as Drug eluting stent (DES), Bare Metal Stent (BMS) and Bioresorbable Vascular Stent (BVS).
This report begins by defining various coronary stents market product types and top brands in the market. It is followed by an overview of market dynamics of the India coronary stents market, which includes FMI analysis of key trends, drivers, restraints and opportunities and key players. It also includes insights into product highlighting regional trends and reimbursement scenario. Impact analyses of key growth drivers and restraints based on the weighted average model have also been included in the report to better equip readers with meaningful insights on ongoing developments in the market.
Primary factors fuelling growth of the global coronary stents market include rapidly ageing population with coronary heart disease indication, strong healthcare consciousness and modified coronary stents. Other factors driving demand for coronary stents market are rising number of PCI procedures and easy access to reimbursement.
Coronary stents products based on advanced technology helps in reducing restenosis after angioplasty. On the contrary, factors such as high cost of stents and regional competition among local players in India are factors expected to hamper market growth in the country in the near future.
Based on product type, the market has been segmented into Drug Eluting Stent, Bare Metal Stent & Bioresorbable Vascular Stent. A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.
Based on raw material type, the market has been segmented into Cobalt Chromium, Stainless Steel, Platinum Chromium, Nickel Titanium and Polymer. A detailed analysis has been provided for every segment in terms of market size, Y-o-Y growth rate, absolute $ opportunity and BPS analysis.
Furthermore, on the basis of end users, hospitals segment is expected to witness significant demand for coronary stents over the forecast period. This trend is expected to be particularly prominent in India, which are increasing access to healthcare services. However, Cardiac Catheterization Laboratories segment is expected to exhibit the highest growth over the forecast period.
The above sections—by product type, raw material and end users—evaluate the present scenario and growth prospects of the India coronary stents market for 2016–2026. We have considered 2015 as the base year and provided data for the forecast period.
In addition, it is imperative to note that in an ever-fluctuating developing economy, we not only conduct forecasts in terms of CAGR, but also provide analysis based on key parameters such as year-on-year (Y-o-Y) growth rates to understand the predictability of the market and to identify the right opportunities across the coronary stents market.
The coronary stents market in terms of product, raw material and end users are analyzed in terms of Basis Point Share (BPS) to understand individual segment’s relative contributions to market growth. This detailed level of information is important for identifying various key trends in the coronary stents market.
Another key feature of this report is the analysis of key segments in terms of absolute dollar opportunity. This is traditionally overlooked while forecasting the market. However, absolute dollar opportunity is critical for assessing the level of opportunity that a provider can look to achieve, as well as to identify potential resources from a sales and delivery perspective of the coronary stents market.
In the final section of the report, competitive landscape of the coronary stents market is included to provide report audiences with a dashboard view, based on categories of providers in the value chain, their respective product portfolios and key differentiators. Key categories of providers covered in the report are coronary stents companies. This section is primarily designed to provide clients with an objective and detailed comparative assessment of key providers specific to a market segment in the coronary stents market value chain and potential players for the same. Report audiences can gain segment-specific vendor insights to identify and evaluate key competitors based on in-depth assessment of capabilities and successes in the coronary stents market.
Detailed profiles of the providers are also included in the scope of the report to evaluate their long-term and short-term strategies, key offerings, SWOT analysis and recent developments in the coronary stents market. Key manufacturers included in the report are Abbott Laboratories, Medtronic, Inc., Biosensors International Group Ltd. And Boston Scientific Inc.
- Drug Eluting Stent
- Bare Metal Stent
- Bioresorbable Vascular Stent
Raw Material Type
- Cobalt Chromium
- Stainless Steel
- Platinum Chromium
- Ambulatory Surgical Centres
- Cardiac Catheterization Laboratories
- Abbott Laboratories
- Medtronic, Inc.
- Biosensors International Group Ltd.
- Boston Scientific Inc.